{
    "doi": "https://doi.org/10.1182/blood.V112.11.4148.4148",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=1125",
    "start_url_page_num": 1125,
    "is_scraped": "1",
    "article_title": "Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation ",
    "article_date": "November 16, 2008",
    "session_type": "Chromosomal Rearrangements",
    "abstract_text": "Most chromosomal translocations in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) involve oncogenes which are either up-regulated or form part of new chimeric genes. The t(2;11)(p21;q23) translocation has been cloned in 19 cases of MDS and AML. In addition to this, we have shown that this translocation is responsible for a strong up-regulation of miR-125b (6 to 90 fold) . In vitro experiments revealed that miR-125b was able to block monocytic and granulocytic differentiation of leukemic cells and primary CD34+ human blasts. Therefore, miR-125b up-regulation may represent a new mechanism of myeloid cell transformation and myeloid neoplasms carrying the t(2;11) translocation define a new clinico-pathological entity.",
    "topics": [
        "leukemia, myelocytic, acute",
        "myeloid cells",
        "translocation (genetics)",
        "leukemic cells",
        "myelodysplastic syndrome",
        "neoplasms",
        "blast cells",
        "chimera organism",
        "granulocytes",
        "monocytes"
    ],
    "author_names": [
        "Marina Bousquet",
        "Cathy Quelen",
        "Roberto Rosati",
        "Ve\u0301ronique Mansat-De Mas",
        "Christian Bastard",
        "Eric Lippert",
        "Pascaline Talmant",
        "Marina Lafage-Pochitaloff",
        "Dominique Leroux",
        "Carine Gervais",
        "Franck Viguie",
        "Jean-Luc Lai",
        "Christine Terre",
        "Georges Delsol",
        "Nicole Dastugue",
        "Cristina Mecucci",
        "Pierre Brousset"
    ],
    "author_affiliations": [
        [
            "Pathology, Inserm U563, Toulouse, France"
        ],
        [
            "Pathology, Inserm U563,, Toulouse, France"
        ],
        [
            "Hematology, CYtogenetics and molecular genetics, Perugia, Italy"
        ],
        [
            "Hematology, Molecular Pathology, Toulouse, France"
        ],
        [
            "Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France"
        ],
        [
            "HA\u0303\u00a9matopoA\u0303e\u0301se leucA\u0303\u00a9mique, UniversitA\u0303\u00a9 Victor Segalen, Bordeaux, France"
        ],
        [
            "Hematology, CHU Hotel-Dieu, Nantes, France"
        ],
        [
            "Hematology, Departement de Cytogenetique, Marseille, France"
        ],
        [
            "Hematology, CYtogenetics and molecular genetics, Grenoble, France"
        ],
        [
            "Laboratoire d\u2019He\u0301matologie, Hopitaux universitaires de Strasbourg, Strasbourg, France"
        ],
        [
            "Hematology, Cytogenetics and molecular genetics, Paris, France"
        ],
        [
            "Hematology, Cytogenetique, Lille, France"
        ],
        [
            "CH de Versailles"
        ],
        [
            "Pathology, Inserm U563, Toulouse, France"
        ],
        [
            "Laboratoire d\u2019He\u0301matologie, Ho\u0302pital Purpan, Toulouse, France"
        ],
        [
            "Hematology, CYtogenetics and molecular genetics, Perugia, Italy"
        ],
        [
            "Pathology, Inserm U563, Toulouse, France"
        ]
    ],
    "first_author_latitude": "33.9415889",
    "first_author_longitude": "-118.40853"
}